Pharmacological Strategy Can Alleviate Multiple Behavioral and Cellular Deficiencies in a Fragile X Syndrome Mouse

Jul 14, 2018 | FXS, Intellectual Disabilities

Fragile X syndrome is a genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment. Usually, males are more severely affected by this disorder than females. https://ghr.nlm.nih.gov/condition/fragile-x-syndrome

As reported in MedicalXpress, A dynamic collaboration laboratories between Emory University and Cincinnati Children’s results in interesting results to be published later this year. The researchers found that a “pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS). FXS is the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders.

pharmacological strategy can alleviate multiple behavioral and The cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders.

Lead Research/Investigative Sites

Emory University National Primate Research Center

Cincinnati Children’s Hospital

Lead Research/Investigators

Gary J. Bassel, PhD

Shannon Gourley, PhD

View article here

0 Comments

Pin It on Pinterest